Patient medication counselling in community pharmacy: evaluation of the quality and content

Table 6 Association between pharmacists’ demographic variables and perception of the quality of counselling provided

Demographics	Categories	N	Quality of patient medication counselling based on the USP-MCBG scale Mean ranks
Demographics	Categories	N	Component 1	Component 2	Component 3	Component 4	USP-MCBG total score
Gender	Male	76	68.67	63.18	62.72	59.91	64.13
	Female	44	46.39	55.88	56.66	61.51	54.23
	p-value^a		0.001*	0.267	0.357	0.808	0.133
Age, years	≤ 25	13	44.08	50.88	51.69	58.65	51.73
	26–45	68	47.40	47.38	47.84	46.13	47.38
	46–65	11	55.45	49.05	46.14	47.18	47.77
	66+	3	51.17	45.67	42.50	47.17	46.67
	p-value^b		0.767	0.975	0.939	0.519	0.964
Country of pharmacy training	Nigeria	116	61.53	62.24	62.09	62.49	62.19
	Outside Nigeria	5	48.60	32.30	35.60	26.40	33.40
	p-value^a		0.419	0.062	0.098	0.024*	0.072
Cadre of pharmacists	Superintendent pharmacist	52	54.05	54.62	55.83	55.19	54.40
	NYSC pharmacist	7	70.50	64.64	61.79	70.57	66.71
	Post internship locum pharmacist	9	54.33	65.39	62.33	62.22	60.11
	Pharmacy manager	21	74.71	68.33	64.67	63.83	68.90
	Staff pharmacist	29	57.21	58.79	60.91	60.57	59.90
	p-value^b		0.162	0.574	0.874	0.739	0.548
Years of community pharmacy experience	≤ 5	84	60.43	62.13	61.26	63.70	61.98
	6–20	29	63.26	61.90	64.97	58.47	62.97
	21–35	5	61.40	52.60	45.80	48.20	46.70
	36+	3	54.50	34.83	40.67	31.17	38.33
	p-value^b		0.970	0.559	0.508	0.322	0.524
Estimated time spent with PCs (min)	≤ 2	5	60.80	88.20	90.20	63.90	81.10
	3–8	59	56.86	61.97	61.08	62.85	60.80
	9–14	37	67.55	57.22	59.24	59.27	60.26
	15+	19	58.00	55.03	53.34	54.71	54.63
	p-value^b		0.518	0.253	0.211	0.828	0.512

USP-MCBG United States Pharmacopeia Medication Counselling Behaviour Guideline
^aMann–Whitney U test
^bKruskal–Wallis test

ISSN: 2052-3211